000 | 01824 a2200529 4500 | ||
---|---|---|---|
005 | 20250514182303.0 | ||
264 | 0 | _c20041109 | |
008 | 200411s 0 0 eng d | ||
022 | _a0268-1161 | ||
024 | 7 |
_a10.1093/humrep/deh185 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aRicci, G | |
245 | 0 | 0 |
_aImpact of highly purified urinary FSH and recombinant FSH on haemostasis: an open-label, randomized, controlled trial. _h[electronic resource] |
260 |
_bHuman reproduction (Oxford, England) _cApr 2004 |
||
300 |
_a838-48 p. _bdigital |
||
500 | _aPublication Type: Clinical Trial; Journal Article; Randomized Controlled Trial | ||
650 | 0 | 4 | _aAdult |
650 | 0 | 4 |
_aAntithrombin III _xmetabolism |
650 | 0 | 4 |
_aEstradiol _xblood |
650 | 0 | 4 |
_aFactor VIII _xmetabolism |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 |
_aFibrinogen _xmetabolism |
650 | 0 | 4 |
_aFollicle Stimulating Hormone, Human _xtherapeutic use |
650 | 0 | 4 |
_aHemostasis _xdrug effects |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aInfertility, Female _xblood |
650 | 0 | 4 |
_aLuteal Phase _xblood |
650 | 0 | 4 |
_aOvulation Induction _xmethods |
650 | 0 | 4 |
_aPeptide Fragments _xblood |
650 | 0 | 4 |
_aPregnancy _xblood |
650 | 0 | 4 |
_aProgesterone _xblood |
650 | 0 | 4 |
_aProtein Precursors _xblood |
650 | 0 | 4 |
_aProtein S _xmetabolism |
650 | 0 | 4 | _aProthrombin |
650 | 0 | 4 | _aProthrombin Time |
650 | 0 | 4 |
_aRecombinant Proteins _xtherapeutic use |
650 | 0 | 4 |
_aTissue Plasminogen Activator _xblood |
700 | 1 | _aCerneca, F | |
700 | 1 | _aSimeone, R | |
700 | 1 | _aPozzobon, C | |
700 | 1 | _aGuarnieri, S | |
700 | 1 | _aSartore, A | |
700 | 1 | _aPregazzi, R | |
700 | 1 | _aGuaschino, S | |
773 | 0 |
_tHuman reproduction (Oxford, England) _gvol. 19 _gno. 4 _gp. 838-48 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1093/humrep/deh185 _zAvailable from publisher's website |
999 |
_c14736312 _d14736312 |